Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE) Ended

2022-503028-29-01 Patients with stage IV EGFR-mutation positive NSCLC tar 4 2021-12-14
Multi-drug treatment for breast cancer patients with brain metastases Ended

2024-510703-11-00 HER2+ metastatic breast cancer with isolated brain prog 4 2021-12-13
Phase I study of IAG933 in patients with advanced Mesothelioma and other solid tumors Ended

2023-508369-34-00 Advanced mesothelioma or other solid tumors harboring c 1 2021-12-07
Study to evaluate the effects of CLR 131 in patients with B-Cell malignancies (CLOVER-1) and expansion study to evaluate the effects of CLR … Ended

2023-508671-37-00 Waldenstrom Macroglobulinemia 4 2021-12-02
An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult … Ended

2024-512903-38-00 Relapsed or refractory B cell acute lymphoblastic leuka 9 2021-12-01
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRA… Ended

2023-506241-30-00 Advanced Colorectal Cancer with KRAS G12C Mutation 5 2021-11-30
A clinical study to assess the efficacy of alpelisib plus fulvestrant in participants with HR-positive, HER2-negative, advanced breast cance… Ended

2023-509133-39-00 Hormone receptor positive, HER2-negative advanced breas 5 2021-11-29
MSI/dMMR tumors in perioperative setting Ended

2024-518127-30-00 MSI/dMMR tumors or EBV+ gastric cancer 4 2021-11-26
A study to evaluate the safety and efficacy of CR6086 in combination with balstilimab (AGEN2034), in patients with pretreated mismatch-repai… Ended

2024-515446-16-00 Pretreated mismatch-repair-proficient and microsatellit 9 2021-11-23
Trial of different schemes of PM14 alone and in combination with radiotherapy in soft tissue sarcomas and other solid tumors Ended

2024-519893-38-00 Soft tissue sarcomas and other solid tumors 9 2021-11-23
Study of Nivolumab and Ipilimumab plus chemotherapy as a treatment for patients with stage IV lung cancer with brain metastases. Ended

2024-513866-20-00 Non-small cell lung cancer with brain metastasis 4 2021-11-18
A Study to Evaluate Efficacy and Safety of Mosunetuzumab in Combination with Lenalidomide in Comparison to Rituximab in Combination with Len… Ended

2023-505807-21-00 Relapsed/refractory follicular lymphoma 5 2021-11-16
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ez… Ended

2024-514034-20-00 non-small cell lung cancer or 3 2021-11-16
A Clinical Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in … Ended

2023-506518-33-00 Locally Advanced or Metastatic Non-Small Cell Lung Canc 5 2021-11-10
An International, Randomized, Double-Blind, Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Pl… Ended

2023-509396-16-00 Metastatic Castration-Resistant Prostate Cancer 5 2021-11-08
Study of Valemetostat Tosylate Monotherapy in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma Ended

2023-507381-13-00 Relapsed/Refractory Peripheral T-Cell Lymphoma 4 2021-11-03
Anti-PD-1, Capecitabine, and Oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle… Ended

2023-509380-24-00 Metastatic upper gastrointestinal cancer, cancer of eso 4 2021-11-01
Treatment combination of Durvalumab, Tremelimumab, Enfortumab Vedotin in patients with muscle invasive bladder cancer ineligible to cisplati… Ended

2023-507342-84-00 Bladder Cancer 5 2021-10-26
Pembrolizumab/placebo plus paclitaxel with or without bevacizumab for platinum-resistant recurrent ovarian cancer. Ended

2023-506177-35-00 Ovarian, fallopian tube, or primary peritoneal carcinom 11 2021-10-23
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment Ended

2024-516292-33-00 Myelodysplastic syndrome (MDS) 3 2021-10-22
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET Driven, Unresectable and Locally Advanced or Metastatic PRCC … Ended

2022-503105-38-00 MET-driven, unresectable and locally advanced or metast 5 2021-10-22
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants with Previously Treated Myelofibrosis Ended

2024-513605-31-00 Myelofibrosis 4 2021-10-21
Adjuvant therapy in stage IV colorectal cancer patients NED Ended

2024-518217-26-00 Stage IV colorectal cancer patients with no evidence of 4 2021-10-20
Isatuximab in combination with Lenalidomide-Dexamethasone compared to Lenalidomide-Dexamethasone in elderly patients (aged ≥70 years) with n… Ended

2024-515581-13-00 Isatuximab in combination with Lenalidomide-Dexamethaso 4 2021-10-20